Teva Pharmaceutical Industries Limited (TEVA) - Company Gross Revenue

Symbol and logo of brand Teva (TEVA)

The scale of generic production creates pricing power for Teva Pharmaceutical Industries (TEVA), although US and EU regulators are putting pressure on drug costs. The company's commercial revenue level clearly confirms this trend, where 17.24 is the current level of the indicator. Meanwhile, management is effectively reducing debt and developing biosimilars despite aggressive price dumping and pressure from low-cost Asian manufacturers.

Teva Pharma - TEVA Revenue and Sales Volume (period 07/04/2022 - 11/18/2026)

Comprehensive metric breakdowns and analytics for tevapharm.com (TEVA)

- current price and projected stock value:
General company analysis:Teva Pharmaceutical Industries
Finished products of Teva Pharmaceutical Industries

Teva Pharmaceutical Industries maintains its status as a global leader in the affordable generics segment. This chart of the company's sold goods visualizes the daily revenue inflow, which currently stands at 17.24. This indicator measures daily consumer activity, where sharp declines signal a risk of capital freeze. The stability of this metric confirms the reliability of global supplies and the trust of healthcare systems. High performance figures guarantee the fundamental resilience of the business.